2015 Outcome Study: Prostate Cancer
To understand the Prostate cancer patient population at Ellis Fischel a retrospective review was performed to evaluate the presenting characteristics and outcomes of Prostate cancer patients at Ellis Fischel Cancer Center from 1998 to 2013.
Ellis Cancer Registry data review was conducted in March 2015 and all cases of prostate cancer were identified and reviewed regarding age and sex between 1998 and 2013. Survival was evaluated based on stage of cancer to information available from the National Cancer database.
Distribution of patients:
1373 men with prostate cancer were seen at Ellis Fischel between 1998 and 2013. The most common type of prostate cancer was adenocarcinoma of the prostate. 53.3 % of patients were diagnosed and treated at Ellis Fischel cancer center. Whereas 42 % of patients were referred to Ellis Fischel after being diagnosed elsewhere consistent with the referral and tertiary care provided by Ellis to the surrounding communities.
Diagnosis and treatment of Prostate cancer At Ellis Fischel:
Between 1998 and 2013, 88- 112 patients were treated annually at Ellis Fischel. The average patients treated per year was around 86 patients per year with the volume increasing to 102 patients in 2013.
Age and Race distribution:
Most of the patients were 50 years or older (97%). Prostate cancer was also diagnosed in younger men, 23% in the 50-59 age group and 2% in the 40-49 years age group. Cancer was rarely detected in men less than 40 year (<1%).
The age distribution in our cohort of patients is similar to that reported in the SEER registry. The risk of developing prostate cancer increases with age as noted in SEER studies.
The risk of getting prostate cancer increases with age. The table below shows the percentage of men (how many out of 100) who will get prostate cancer over different time periods. The time periods are based on the man’s current age.
For example, go to current age 60. The table shows 5.84% of men who are now 60 years old will get prostate cancer sometime during the next 10 years. That is, 5 or 6 out of every 100 men who are 60 years old today will get prostate cancer by the age of 70.
Source: Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2012, National Cancer Institute. Bethesda, MD,http://seer.cancer.gov/csr/1975_2012/browse_csr.php?sectionSEL=23&pageSEL=sect_23_table.10.html, based on November 2014 SEER data submission, posted to the SEER Web site, April 2015.
Prostate cancer was most commonly diagnosed in white men (92%). 101 patients that were diagnosed with prostate cancer in this time frame were black (7%). Very few patients belonged to other races.
The primary treatment offered by stage of disease is similar to the treatment patterns noted in the NCDB. The rate patients receiving radiation only as the primary treatment of choice was higher than the national average in both Stage I and II disease. In the Stage III cohort the percentage of men receiving surgery as the primary treatment was higher in patients treated at Ellis Fischel.
Stage of Thyroid Cancer and Survival:
Prostate cancer survival data for staging was reviewed from 2003 to 2008. Most of the patients were diagnosed at stage 1. This information was compared to patients in the National Cancer database. Thyroid cancer patients treated at Ellis Fischel showed similar 5 year survival compared to NCD at stage 1, 2, and 3. The 5 year survival for stage 4 patients shows a slightly better outcome in the NCDB, however the numbers are small and the findings may be due to a low power in the EFCC group.